Any feedback?
Literature summary for 2.1.1.354 extracted from
- ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity (2009), Mol. Endocrinol., 23, 1556-1562.
Cloned(Commentary)
| Cloned (Comment) | Organism |
|---|---|
| expressed HEK-293 cells | Mus musculus |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Mus musculus | - |
- |
- |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| S-adenosyl-L-methionine + histone H3(K4) | trimethylation of histone H3(K4) | Mus musculus | ? | - |
? |  |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| H3K4 methyltransferase | - |
Mus musculus |
| histone H3 lysine 4 methyltransferase activity | - |
Mus musculus |
| MLL3 | part of the activating signal cointegrator-2 complex | Mus musculus |
| MLL4 | part of the activating signal cointegrator-2 complex | Mus musculus |
General Information
| General Information | Comment | Organism |
|---|---|---|
| physiological function | MLL3 and MLL4 function redundantly with farnesoid X receptor transactivation | Mus musculus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
